emedastine has been researched along with Granulocytic Leukemia in 1 studies
emedastine: structure given in first source
emedastine : 1-Methyl-1,4-diazepane in which the hydrogen attached to the nitrogen at position 4 is substituted by a 1-(2-ethoxyethyl)-1H-benzimidazol-2-yl group. A relatively selective histamine H1 antagonist, it is used as the difumatate salt for allergic rhinitis, urticaria, and pruritic skin disorders, and in eyedrops for the symptomatic relief of allergic conjuntivitis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, JL | 1 |
| Kang, HN | 1 |
| Kang, MH | 1 |
| Yoo, YA | 1 |
| Kim, JS | 1 |
| Choi, CW | 1 |
1 other study available for emedastine and Granulocytic Leukemia
| Article | Year |
|---|---|
The oral iron chelator deferasirox induces apoptosis in myeloid leukemia cells by targeting caspase.
Topics: Animals; Antineoplastic Agents; Apoptosis; Benzimidazoles; Benzoates; Caspases; Cell Cycle; Cell Pro | 2011 |